Novel Cancer-preventing Topical Immunotherapy Agent May Stave Off cSCC
Topical calcipotriol plus 5-fluorouracil (5-FU) may prevent squamous cell carcinoma, with benefits lasting five years after treatment, according to a study in the Journal of Clinical Investigation. The immunotherapy agent activates specific components of the adaptive immune system, particularly CD4+ T helper cells, which are not known to be involved in traditional cancer treatments. “One of […]